An Exceedingly Rare Case of Liraglutide-Induced Liver Injury.

IF 0.6 Q4 GASTROENTEROLOGY & HEPATOLOGY

Case Reports in Gastrointestinal Medicine Pub Date : 2021-08-23 eCollection Date: 2021-01-01 DOI:10.1155/2021/6306149

Swetha Parvataneni, Rajarajeshwari Ramachandran, Eric Then, Tyler Grantham, Vinaya Gaduputi

引用次数: 2

Abstract

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.

查看原文本刊更多论文

利拉鲁肽致肝损伤一例极为罕见。

利拉鲁肽是一种胰高血糖素样肽-1 (GLP-1)受体激动剂，用于治疗2型糖尿病。我们报告第二例利拉鲁肽引起的肝损伤，停药后肝损伤完全消退。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊